The Effect of Education Given to Patients With Heart Failure on Self-care, Drug Compliance and Quality of Life.
Heart Failure
About this trial
This is an interventional treatment trial for Heart Failure focused on measuring Heart Failure, Transtheoretic model, Treatment Compliance, Self-care, Tele-health, Patient education
Eligibility Criteria
Inclusion Criteria:
- Have no communication barriers to affect cognitive functions,
- Ejection-Fraction over 20
- Diagnosed with Heart Failure for at least 6 months
- Able to use tele-health applications (smartphone and application)
Exclusion Criteria:
- Patients with communication difficulties
- Patients who cannot use tele-health applications
Sites / Locations
- Harran UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention group
Control
Study group intervention: 7 sessions of transtheoretical model-based interview (2 in the first month, a total of 7 times, once a month), a structured disease education through transtheoretical model-based telehealth practices, and 6-month follow-up. After the participants are included in the study, a health education structured according to the Transtheoretical model will be given to the patients in the study group through tele-health applications. The patients in the intervention group will be trained through tele-health practices for at least 25-30 minutes on a transtheoretical basis, every 2 weeks in the first month and once a month in the following months. Tele-health applications include phone monitoring, SMS notification and application applications. In the 6-month follow-up, there will be 2 follow-ups as pre-test (1st month) and post-test (6th month). Behavioral: 7 sessions of behavior change training based on the transtoerytic model
No notification will be made to the relatives of the patients in the control group. Control group patients will be called for routine control in line with their usual plans. After a total of 6 months from the beginning, the self-care and treatment compliance levels of the patients in the control group will be examined. There will be 2 follow-ups as pre-test (1st month) and post-test (6th month).